Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP,30 mg/30 mL (1 mg/mL) Multiple-Dose Vial".
Press Release Dec 23 2025
Filed with NSE · · 3 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Dec 16 2025
- Press Release Dec 11 2025
- Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
- Press Release Nov 27 2025
- Press Release Nov 25 2025
Later from Glenmark Pharmaceuticals
- Press Release Jan 30 2026
- Q3FY 2025-26
- Glenmark Pharmaceuticals Limited Press Release Feb 27 2026
- Glenmark Pharmaceuticals Limited Press Release Mar 04 2026
- Glenmark Pharmaceuticals Limited Press Release Mar 16 2026
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals